Results from a new HDA Research Foundation survey indicate that the pharmaceutical supply chain is entering a critical phase in achieving the transaction data connections required to comply with the Drug Supply Chain Security Act (DSCSA) in 2023.
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released a statement regarding the Biden-Harris administration’s authorization of COVID-19 vaccine booster doses.
The Healthcare Distribution Alliance (HDA) honored AmerisourceBergen with the 2021 Distribution Management Award in recognition of the company’s engagement with manufacturer and dispensing trading partners during the COVID-19 pandemic. The award was presented in conjunction with the 2021 Distribution Management Virtual Conference and Expo.
The Healthcare Distribution Alliance (HDA) honored 10 pharmaceutical and consumer product manufacturers with Distribution Industry Awards for Notable Achievements in Healthcare (DIANA Awards).
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released a statement in response to the release of key findings from the Biden-Harris Administration 100-day supply chain review.
John Parker
(703) 885-0216
Farah Simonett
(703) 885-0269
